MD News and Press, Mednax Inc. From 04/28/22

Mednax press release (NYSE:MD): Q1 Non-GAAP EPS of $0.33 beats by $0.06. Revenue of $482.23M (+7.9% Y/Y) beats by $10.94M. “Our bottom line results were in line with our expectations and reflect continued patient volume growth,” said Mark S. Ordan, Chief Executive Officer o...

Mednax (NYSE:MD) is scheduled to announce Q1 earnings results on Thursday, April 28th, before market open. The consensus EPS Estimate is $0.27 (+12.5% Y/Y) and the consensus Revenue Estimate is $471.29M (+5.5% Y/Y). Over the last 2 years, MD has beaten EPS estimates 63% of the time and has be...

Mednax, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, April 28, 2022 at 9:00 a.m. ET, to discuss results from operations for the quarter ended March 31, 2022. A detailed press release will be issued the morning of April 28, 2022 before the securities mar...

Mastercard (MA) completed its acquisition of Dynamic Yield from McDonald's (MCD), strengthening Mastercard's range of consumer engagement and loyalty services that help brands improve their customer experiences across channels. With teams in Tel Aviv, New York City and around t...

Jeff Smith’s 13F portfolio value increased from $5.46B to $7.22B this quarter. Starboard Value increased Huntsman Corporation while decreasing Merit Med Systems. They also added GoDaddy, ON Semi, and Colfax while dropping Box Inc. The largest three individual stock position...

Despite possessing solid long-term growth prospects on the back of rising demand from an aging population, many healthcare stocks have been hard hit by the broader market sell-offs over the past couple of months. But given the near-inelastic demand for healthcare solutions and the industry&#x...

Brand evolution reflects breadth of clinical expertise and exclusive focus on providing the highest quality services across the women’s and children’s continuum of care Mednax, Inc. (NYSE: MD) today announced that its affiliated practices will adopt the Pediatr...

Leading industry conferences address the latest topics in neonatal management designed to improve outcomes for premature and critically ill newborns Mednax, Inc. (NYSE: MD) and its Pediatrix-affiliated practices, the nation’s leading providers of highly specialized he...

Mednax, Inc. (NYSE: MD) today announced that it will present on Monday, February 28, 2022 at 10:00 a.m. ET to investors attending J.P. Morgan’s 2022 Global High Yield and Leveraged Finance Conference in Miami. The presentation will be broadcast through live audio webcasts. ...

MEDNAX, Inc. (MD) Q4 2021 Earnings Conference Call February 17, 2022, 9:00 AM ET Company Participants Mark Ordan – Chief Executive Officer Marc Richards – Chief Financial Officer Jim Swift – Chief Development Officer Charles Lynch – Senior Vice President, Finance &...